• Verónica García, Laura Corbalán, Sandra Baquero, Esther García-Esquinas, and José Antonio Sacristán.
• Universidad Carlos III, Madrid, España; Departamento Médico, Lilly España, Madrid, España.
• Aten Primaria. 2020 Dec 1; 52 (10): 697-704.

ObjectiveDescribe the characteristics of the therapeutic positioning reports (TPRs) published in Spain in the period 2013-2019.Design And Data SourceSystematic review of all TPRs published in the website of the Spanish Agency of Medicines and Health Products (AEMPS).Selection Of StudiesAll TPRs published since May 2013, until March 2019 DATA EXTRACTION: The main variables collected were the therapeutic groups assessed, the number of TPRs, the time of elaboration, the existence of restrictions versus the authorized indications and the information on the efficiency of medicines.ResultsDuring the period under review, 214 TPRs were carried out, with an average production time of 8.8 months, almost three times the objective of 3-month initially set. 57% of the TPRs established restrictions of use with respect to the approved indications. 26% of TPRs referred to the existence of economic data, although none included details on the efficiency. 10% of TPRs were updated.ConclusionsFor TPRs to meet their objective of improving the efficiency of the assessment process and the consistency in the decisions on price, reimbursement and financing of medicines by the SNS, the deadlines established for publication must be met, incorporating systematically information on the efficiency of the drugs and including periodic updates with the new information generated.Copyright © 2020 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.

10 keywords...

hide…